Recombinant multi-species HDAC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HDAC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene product belongs to the histone deacetylase family. Histone deacetylases act via the formation of large multiprotein complexes, and are responsible for the deacetylation of lysine residues at the N-terminal regions of core histones (H2A, H2B, H3 and H4). This protein forms transcriptional repressor complexes by associating with many different proteins, including YY1, a mammalian zinc-finger transcription factor. Thus, it plays an important role in transcriptional regulation, cell cycle progression and developmental events. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
The Alternative Names of target: D10Wsu179e,HD2,HDAC2,Hdac2,Histone deacetylase 2,KDAC2,Protein deacylase HDAC2,RPD3,YAF1,Yy1bp,mRPD3
Go
to HDAC2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T51191-Ag-1/ GM-Tg-hg-T51191-Ag-2 | Human HDAC2 protein | Human |
| GM-Tg-rg-T51191-Ag-1/ GM-Tg-rg-T51191-Ag-2 | Rat HDAC2 protein | Rat |
| GM-Tg-mg-T51191-Ag-1/ GM-Tg-mg-T51191-Ag-2 | Mouse HDAC2 protein | Mouse |
| GM-Tg-cynog-T51191-Ag-1/ GM-Tg-cynog-T51191-Ag-2 | Cynomolgus/Rhesus macaque HDAC2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T51191-Ag-1/ GM-Tg-felg-T51191-Ag-2 | Feline HDAC2 protein | Feline |
| GM-Tg-cang-T51191-Ag-1/ GM-Tg-cang-T51191-Ag-2 | Canine HDAC2 protein | Canine |
| GM-Tg-bovg-T51191-Ag-1/ GM-Tg-bovg-T51191-Ag-2 | Bovine HDAC2 protein | Bovine |
| GM-Tg-equg-T51191-Ag-1/ GM-Tg-equg-T51191-Ag-2 | Equine HDAC2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T51191-Ag-1/ GM-Tg-hg-T51191-Ag-2;
GM-Tg-rg-T51191-Ag-1/ GM-Tg-rg-T51191-Ag-2;
GM-Tg-mg-T51191-Ag-1/ GM-Tg-mg-T51191-Ag-2; GM-Tg-cynog-T51191-Ag-1/ GM-Tg-cynog-T51191-Ag-2; GM-Tg-felg-T51191-Ag-1/ GM-Tg-felg-T51191-Ag-2; GM-Tg-cang-T51191-Ag-1/ GM-Tg-cang-T51191-Ag-2; GM-Tg-bovg-T51191-Ag-1/ GM-Tg-bovg-T51191-Ag-2; GM-Tg-equg-T51191-Ag-1/ GM-Tg-equg-T51191-Ag-2 |
| Products Name | HDAC2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | HDAC2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HDAC2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.